| Metric | Q2 FY27 | Q1 FY27 | Q2 FY26 |
|---|---|---|---|
| Revenue from operations | 0.1 | 0.1 | 0.1 |
| Other income | 0.5 | 0.5 | 0.5 |
| Total income | 0.6 | 0.6 | 0.6 |
| Profit before exceptional items & tax | 0.2 | 0.2 | 0.1 |
| Profit before tax | 0.2 | 0.2 | 0.1 |
| Net profit | 0.1 | 0.1 | 0.1 |
| Operating margin | 33.3% | 33.3% | 16.7% |
A dash means the filing did not report that period; n/m means not meaningful (margin on near-zero revenue). Growth is not shown when either period was a loss. Operating profit excludes other income.
| Net profit, year on year | +0.00% |
|---|---|
| Net profit, quarter on quarter | +0.00% |
| Revenue, year on year | +0.00% |
| Operating profit, year on year | +25.00% |
BSE results filing, NSE: EMMESSA. Figures extracted from the filing.
Emmessar Biotech & Nutrition Ltd: key numbers
- Share price
- ₹23.63
- Market cap
- ₹11.81 Cr
- Revenue (annual)
- ₹0.37 Cr
- Net profit (annual)
- ₹0.44 Cr
- P/E (TTM)
- 29.8×Sector 52.8×
- Promoter holding
- 59.53%+0.00% QoQ
- FII holding
- 0.00%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Emmessar Biotech & Nutrition Ltd
All →Emmessar Biotech & Nutrition Board Meeting Date
Emmessar Biotech & Nutrition scheduled a board meeting for 31 October 2026 to consider unaudited quarterly results ended 30 September 2026. The trading window stays closed until 02 November 2026.
Emmessar Biotech & Nutrition Other Announcement
Emmessar Biotech & Nutrition Ltd filed its quarterly shareholding pattern for the period ended September 30, 2026, in compliance with regulatory reporting standards.
Emmessar Biotech & Nutrition Annual General Meeting
Emmessar Biotech & Nutrition Ltd conducted its 34th Annual General Meeting on September 29, 2026. Key business included adopting financial statements and re-appointing directors.
Emmessar Biotech & Nutrition Other Announcement
Emmessar Biotech & Nutrition informed shareholders without registered email addresses about accessing the Annual Report and 34th AGM Notice via the company's website.
Emmessar Biotech & Nutrition Annual General Meeting
Emmessar Biotech & Nutrition Limited has issued a notice for its 34th Annual General Meeting, scheduled to be held on September 29, 2026, via video conferencing.
Emmessar Biotech & Nutrition Q1 FY27 Results: Net Profit ₹0.1 Cr, Down 50.0% YoY
Emmessar Biotech & Nutrition Ltd reported revenue from operations of ₹0.1 Cr (+0.0% YoY) and net profit of ₹0.1 Cr (-50.0% YoY) for Q1 FY27.
- Key figure
- Net profit ₹0.1 Cr · -50.0% YoY